NEW YORK, May 25, 2015 Cancer is a pathology characterized by uncontrolled and cellular proliferation which causes the death of millions of people worldwide every year. Lifestyles, aging, population growth and rising treatment costs, are new challenges for the fight against cancer. Lifestyle (diet and smoking), exposure to carcinogens, and hereditary factors are the main causes of cancer, amongst which the most commonly diagnosed are lung, breast, and colorectal cancer.
With almost 22 million new annual cases expected in 2030, it is essential that the domain of oncology evolves and develops. The needs of patients in oncology change requiring this special branch of medical study, diagnostic and therapeutic management to reflect on new diagnostic and therapeutic approaches. Thanks to promising, innovative treatments and new therapies, we are already observing undeniable advances which have a real impact on the chances of survival.
The experts in oncology are looking toward a future focused on personalized medicine, out-patient care and successful methods of cured patients. The development of techniques for mini or non-invasive procedures and high-definition scanners dedicated to patients, are also major topics for future development.
Featuring 30 companies' profiles such as Novartis International and Sanofi Aventis, and 30 R&D Laboratories such as the The Masonic Cancer Center of University of Minnesota, or the Department of Pharmaceutical Sciences of the Utrecht University, this report is ideal for anyone wanting:
- Identify R&D Partners,
- Obtain IP & Technologic Intelligence,
- Develop your R&D Partnerships,
- And also benchmark competitors.
…all on a global scale.
You will also find 50 expert's profiles, containing their scientific works and details of their field of expertise.
These Key Innovation Leaders are based across the 3 main geographical areas around the globe for scientific expertise: North America (USA, Canada…), Europe (France, Germany…) and Eastern Asia (Japan, Korea, Taiwan…).
For each of them, you will receive a scientific profile updated at time of order, a selection of focused works and a presentation of their collaborative partners, as well as an in-depth explanation of why companies such as Novartis International are leaders on Oncology.
A Panorama is composed of:
- A global overview of the subject (issues, distribution of sources of expertise, international networks, European projects, main standards...)
- A selection of scientific profiles of actors (research centers , companies, experts)
- A selection of targeted works (from 50 different types of scientific and technical documents from more than 250 data sources).
Here are some examples of our data sources:
Research institutes databases (NASA, MIT, Fraunhofer, ...)
Patent Databases (European Patent Office, USPTO, ...)
Thematic Databases (MedLine/PubMed, INRA, ...)
Project Databases (Cordis FP-7, FP-6, ...)
Panorama are generated and updated with the unique mapping technology developed by Expernova, which covers 52 countries. Expernova data base is constantly growing, so each Panorama updated at any given time is potentially different from the others Panorama generated at other times on the same subject.
SCOPE OF THE PANORAMA
medical oncology, radiation oncology, pharmaceutical composition, clinical trial, malignant tumor, pediatric oncology, cancer, radiation therapy, antineoplastic agent, oncological disease, oncology nursing, gynecologic oncology
Read the full report: http://www.reportlinker.com/p02868610-summary/view-report.html
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
Intl: +1 339-368-6001